<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221218056853N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-26</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Laser therapy in lower lip paresthesia and dysesthesia</public_title>
      <acronym>LLLT</acronym>
      <scientific_title>Evaluation of the adjunctive effect of photobiomodulation therapy with Nd: YAG laser(1064nm) on decrease of lower lip paresthesia and dysesthesia in patients with inferior alveolar nerve damage</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67488</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method is simple and its unit is individual. The randomization tool will be a table of random numbers. Based on this, the type of intervention will be marked with code A (real laser therapy) and code B (placebo) and will be placed inside sealed envelopes. Then the envelopes will be placed in a bag and mixed. The envelopes will be randomly taken out of the bag and will be presented to the relevant intervention patients by observing the intervention code. None of the patients will be informed about the intervention of another patient, Blinding description: In this study, it will be explained to the patients that there is a possibility of their placement in the real or fake laser therapy group, but the patients will not know their group and the laser device will be used in both groups. Patients wear blindfolds during laser therapy to protect them from laser radiation and do not notice the real or fake laser therapy. Laser therapy is performed by a person who has no knowledge of real or fake laser therapy (only the aiming beam is turned on) and evaluates the results of the study in each session. Data analysis will also be done by a person who does not know about the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Lower lip paresthesia and/or dysesthesia.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: Patients with paresthesia and dysesthesia of the lower lip with less than 6 months of injury who receive routine treatment plus low level laser therapy. Intervention 2: First Control group: Patients with paresthesia and dysesthesia of the lower lip less than 6 months after the injury, who receive routine treatment plus placebo. Intervention 3: Second Intervention group: Patients with paresthesia and dysesthesia of the lower lip with more than 6 months of injury who receive routine treatment plus low level laser therapy. Intervention 4: Second Control group: Patients with paresthesia and dysesthesia of the lower lip more than 6 months after the injury, who receive routine treatment plus placebo.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals.

When:
The access period starts from 2023

To whom:
All people can apply for study documents.

Conditions:
The data of this study can be used to investigate the effect of low level laser therapy in patients who only have paresthesia or dysesthesia of the lower lip.

Where to obtain:
Meghdad Eslami
0098 9148528993

How to obtain:
After submitting the application, the study documentation file will be sent as soon as possible

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Meghdad Eslami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.346, 2th Golestan Ave, Ostandari Blvd</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5158943846</zip>
        <telephone>+98 41 3660 9691</telephone>
        <email>meghdadeslami72@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Meghdad Eslami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.346, 2th Golestan Ave, Ostandari Blvd</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5158943846</zip>
        <telephone>+98 41 3660 9691</telephone>
        <email>meghdadeslami72@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Paresthesia and dysesthesia of the lower lip, which are classified as 1, 2, and 3 in the Sunderland classification
Not performing previous intervention related to nerve damage</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The presence of mass in the face, jaw and neck area
Active infection in the chin and jaw area
Involvement of other branches of the trigeminal nerve except the inferior alveolar nerve</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R20.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Paresthesia of skin</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: Patients with paresthesia and dysesthesia of the lower lip with less than 6 months of injury who receive routine treatment plus low level laser therapy.</i_keyword>
      <i_keyword>First Control group: Patients with paresthesia and dysesthesia of the lower lip less than 6 months after the injury, who receive routine treatment plus placebo.</i_keyword>
      <i_keyword>Second Intervention group: Patients with paresthesia and dysesthesia of the lower lip with more than 6 months of injury who receive routine treatment plus low level laser therapy.</i_keyword>
      <i_keyword>Second Control group: Patients with paresthesia and dysesthesia of the lower lip more than 6 months after the injury, who receive routine treatment plus placebo.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Visual analogue scale (VAS). Timepoint: Before starting the intervention and in every 10 laser therapy sessions. Method of measurement: In this way, Scale = 0 is considered for lack of sensitivity and Scale = 10 is considered as normal sensitivity and the patient is asked to choose a number between 0 and 10.</prim_outcome>
      <prim_outcome>Two-point discrimination test. Timepoint: Before starting the intervention and in every 10 laser therapy sessions. Method of measurement: Static two-point discrimination test is performed by two objects on the skin, which can be used to measure the distance between two points. These objects should be blunt and non-sharp and have the ability to stimulate pain receptors. The closest distance that the patient can distinguish two points from one point is recorded.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-04</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Faculty of Dentistry, Tabriz University of Medical Sciences, Golgasht Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
